Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASPEN AEROGELS INCASPN · Entity 5645 | Director | June 02, 2022 | June 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASPEN AEROGELS INC
Report date June 02, 2022 · Filed June 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 355,182 |
Reported balance
After 2022-06-02 transaction · row 1
1 source rowRow 1 · 2022-06-02 · Grant · Acquired 2,699 · Balance 355,182 F1: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.89 · Expires 2032-06-02 | Direct | 3,178 |
Reported balance
After 2022-06-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-02 · Grant · Acquired 3,178 · Balance 3,178 F3: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Robert Gervis 2014 Grantor Retained Annuity Trust | 72,491 |
Reported balance
Holding disclosure · report date 2022-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 72,491 F2: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023.
F2: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee.
F3: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2022 Filed Jun 6, 2022 23:06 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 3,178 | $0.00 Strike: $18.89 | $0.00 |
DisclosureSEC source: 0001209191-22-034701 · doc4.xml · derivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178 Underlying: Common Stock · 3,178 shares Expires 2032-06-02 F3 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:06 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 2,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034701 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,182 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 20:37 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 135,870 | $33.12 | $4,500,014.40 |
DisclosureSEC source: 0001209191-22-020789 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,483 F1 · shares: All 135,870 shares were purchased by Mr. Gervis from the issuer in the issuer's at-the-market offering pursuant to the issuer's at-the-market sales agreement Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 9,817 | $0.00 Strike: $6.79 | $0.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · derivative · entry 13 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,817 shares Expires 2030-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 11,950 | $0.00 Strike: $6.08 | $0.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · derivative · entry 12 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,950 shares Expires 2029-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 13,517 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · derivative · entry 11 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,517 shares Expires 2028-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 17,019 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · derivative · entry 10 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,019 shares Expires 2027-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 14,799 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · derivative · entry 9 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,799 shares Expires 2026-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 10,228 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · derivative · entry 8 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,228 shares Expires 2025-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 9,817 | $6.79 | $66,657.43 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · nonDerivative · entry 6 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 11,950 | $6.08 | $72,656.00 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · nonDerivative · entry 5 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 13,517 | $5.27 | $71,234.59 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · nonDerivative · entry 4 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 17,019 | $4.15 | $70,628.85 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · nonDerivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 14,799 | $4.75 | $70,295.25 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 00:01 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 10,228 | $6.61 | $67,607.08 |
DisclosureSEC source: 0001209191-21-067038 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:24 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock (Right-to-Buy) · Derivative | 3,088 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001209191-21-037651 · doc4.xml · derivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,088 Underlying: Common Stock · 3,088 shares Expires 2031-06-01 F3 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 1, 2022, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2022. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:24 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 2,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037651 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,283 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 1, 2022, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2022. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:34 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 9,817 | $0.00 Strike: $6.79 | $0.00 |
DisclosureSEC source: 0001209191-20-038197 · doc4.xml · derivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,817 Underlying: Common Stock · 9,817 shares Expires 2030-06-18 F3 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 18, 2021 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2021. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:34 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 7,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038197 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,794 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 18, 2021 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2021. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:12 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 11,950 | $0.00 Strike: $6.08 | $0.00 |
DisclosureSEC source: 0001209191-19-038555 · doc4.xml · derivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,950 Underlying: Common Stock · 11,950 shares Expires 2029-06-19 F3 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 19, 2020 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:12 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 8,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038555 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,283 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 19, 2020 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2020. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:29 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 13,517 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0001209191-18-039208 · doc4.xml · derivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,517 Underlying: Common Stock · 13,517 shares Expires 2028-06-20 F3 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 20, 2019 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2019. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:29 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 9,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039208 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,895 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 20, 2019 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2019. Read SEC document |
| August 31, 2017 Filed Aug 31, 2017 22:22 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 100 | $4.00 | $400.00 |
DisclosureSEC source: 0001209191-17-050936 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 72,491 F2 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| August 31, 2017 Filed Aug 31, 2017 22:22 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 100 | $4.00 | $400.00 |
DisclosureSEC source: 0001209191-17-050936 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,218 F1 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 23:23 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 17,019 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001209191-17-040260 · doc4.xml · derivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,019 Underlying: Common Stock · 17,019 shares Expires 2027-06-14 F3 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 14, 2018 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2018. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 23:23 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 12,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040260 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,118 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 14, 2018 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2018. Read SEC document |
| May 05, 2017 Filed May 8, 2017 21:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 700 | $4.00 | $2,800.00 |
DisclosureSEC source: 0001209191-17-030634 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,829 F3 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. Read SEC document |
| May 05, 2017 Filed May 8, 2017 21:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 700 | $4.00 | $2,800.00 |
DisclosureSEC source: 0001209191-17-030634 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 72,391 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F2 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| May 04, 2017 Filed May 4, 2017 23:52 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 200 | $4.00 | $800.00 |
DisclosureSEC source: 0001209191-17-030155 · doc4.xml · nonDerivative · entry 4 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,129 F4 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.998 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 04, 2017 Filed May 4, 2017 23:52 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 200 | $4.00 | $800.00 |
DisclosureSEC source: 0001209191-17-030155 · doc4.xml · nonDerivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 71,691 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| May 03, 2017 Filed May 4, 2017 23:52 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 202 | $4.00 | $808.00 |
DisclosureSEC source: 0001209191-17-030155 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,929 F4 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. Read SEC document |
| May 03, 2017 Filed May 4, 2017 23:52 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 189 | $4.00 | $756.00 |
DisclosureSEC source: 0001209191-17-030155 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 71,491 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| May 01, 2017 Filed May 2, 2017 20:31 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 140 | $4.00 | $560.00 |
DisclosureSEC source: 0001209191-17-029202 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,727 F3 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. Read SEC document |
| May 01, 2017 Filed May 2, 2017 20:31 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 110 | $4.00 | $440.00 |
DisclosureSEC source: 0001209191-17-029202 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 71,302 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F2 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 26, 2017 Filed Apr 26, 2017 22:08 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 2,405 | $4.00 | $9,620.00 |
DisclosureSEC source: 0001209191-17-028249 · doc4.xml · nonDerivative · entry 4 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,587 F4 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F7 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.98 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 26, 2017 Filed Apr 26, 2017 22:08 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 2,000 | $4.00 | $8,000.00 |
DisclosureSEC source: 0001209191-17-028249 · doc4.xml · nonDerivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 71,192 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F6 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.985 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 22:08 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 800 | $4.00 | $3,200.00 |
DisclosureSEC source: 0001209191-17-028249 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,182 F4 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 22:08 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,100 | $4.00 | $4,400.00 |
DisclosureSEC source: 0001209191-17-028249 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 69,192 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.999 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 00:20 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 6,711 | $4.00 | $26,844.00 |
DisclosureSEC source: 0001209191-17-028026 · doc4.xml · nonDerivative · entry 4 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,382 F4 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F7 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.98 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 00:20 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 6,336 | $4.00 | $25,344.00 |
DisclosureSEC source: 0001209191-17-028026 · doc4.xml · nonDerivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 68,092 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F6 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 21, 2017 Filed Apr 25, 2017 00:20 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 2,554 | $3.99 | $10,190.46 |
DisclosureSEC source: 0001209191-17-028026 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,671 F4 · kind: The purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.965 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 21, 2017 Filed Apr 25, 2017 00:20 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 2,600 | $3.99 | $10,374.00 |
DisclosureSEC source: 0001209191-17-028026 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 61,756 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.96 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 20, 2017 Filed Apr 20, 2017 23:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 5,400 | $3.99 | $21,546.00 |
DisclosureSEC source: 0001209191-17-027780 · doc4.xml · nonDerivative · entry 4 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,117 F4 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 20, 2017 Filed Apr 20, 2017 23:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 5,300 | $3.99 | $21,147.00 |
DisclosureSEC source: 0001209191-17-027780 · doc4.xml · nonDerivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 59,156 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 23:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 4,600 | $3.98 | $18,308.00 |
DisclosureSEC source: 0001209191-17-027780 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,717 F4 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.96 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 23:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 4,200 | $3.98 | $16,716.00 |
DisclosureSEC source: 0001209191-17-027780 · doc4.xml · nonDerivative · entry 1 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 53,856 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.96 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 18, 2017 Filed Apr 18, 2017 21:17 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 8,311 | $3.99 | $33,160.89 |
DisclosureSEC source: 0001209191-17-027324 · doc4.xml · nonDerivative · entry 4 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,117 F4 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 18, 2017 Filed Apr 18, 2017 21:17 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 8,400 | $3.99 | $33,516.00 |
DisclosureSEC source: 0001209191-17-027324 · doc4.xml · nonDerivative · entry 3 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Robert Gervis 2014 Grantor Retained Annuity Trust Disclosed balance after: 49,656 F1 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the Robert Gervis 2014 Grantor Retained Annuity Trust adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 21:17 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 3,599 | $3.98 | $14,324.02 |
DisclosureSEC source: 0001209191-17-027324 · doc4.xml · nonDerivative · entry 2 Gervis Robert M. · CIK 0001472399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,806 F4 · kind: This purchase of shares was effected pursuant to a Rule 10b5-1 purchase plan of the reporting person adopted on November 18, 2016. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.